147 related articles for article (PubMed ID: 10079372)
1. Bcl-2 and p53 immunoprofile in Kaposi's sarcoma.
Pillay P; Chetty R; Reddy R
Pathol Oncol Res; 1999; 5(1):17-20. PubMed ID: 10079372
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of Bcl-2 in Kaposi's sarcoma lesions varies according to histopathologic stage, whereas expression of Bcl-x and Mcl-1 differs according to human immunodeficiency virus serologic status of patients.
Fernández-Figueras MT; Puig L; Fernández-Vasalo A; Esquius M; Montero MA; Ariza A
Mod Pathol; 2000 Apr; 13(4):438-45. PubMed ID: 10786812
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of p53 and Ki-67 proteins in classic and iatrogenic Kaposi's sarcoma.
Hodak E; Hammel I; Feinmesser M; Zelinger A; Maron L; Sulkes J; David M
Am J Dermatopathol; 1999 Apr; 21(2):138-45. PubMed ID: 10218673
[TBL] [Abstract][Full Text] [Related]
4. The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma.
Dada MA; Chetty R; Biddolph SC; Schneider JW; Gatter KC
Histopathology; 1996 Aug; 29(2):159-63. PubMed ID: 8872150
[TBL] [Abstract][Full Text] [Related]
5. Expression and mutation of the tumor suppressor gene p53 in AIDS-associated Kaposi's sarcoma.
Li JJ; Huang YQ; Cockerell CJ; Zhang WG; Nicolaides A; Friedman-Kien AE
Am J Dermatopathol; 1997 Aug; 19(4):373-8. PubMed ID: 9261472
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature.
Simonart T; Hermans P; Schandene L; Van Vooren JP
Br J Dermatol; 2000 Sep; 143(3):557-63. PubMed ID: 10971329
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
Dogusoy G; Karayel FA; Göcener S; Göksel S
Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
[TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
9. Charting a new course through the chaos of KS (Kaposi's sarcoma).
Nickoloff BJ; Foreman KE
Am J Pathol; 1996 May; 148(5):1323-9. PubMed ID: 8623902
[No Abstract] [Full Text] [Related]
10. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
Varricchio F; Husain SR; Leland P; Gill P; Puri RK
Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
[TBL] [Abstract][Full Text] [Related]
11. Immunihistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma.
Morris CB; Gendelman R; Marrogi AJ; Lu M; Lockyer JM; Alperin-Lea W; Ensoli B
Am J Pathol; 1996 Apr; 148(4):1055-63. PubMed ID: 8644847
[TBL] [Abstract][Full Text] [Related]
12. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
Mizera-Nyczak E; Dyszkiewicz W; Heider KH; Zeromski J
Tumour Biol; 2001; 22(1):45-53. PubMed ID: 11054026
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma classification: a problem not yet defined.
Cottoni F; Montesu MA
Int J Dermatol; 1996 Jul; 35(7):480-3. PubMed ID: 8809601
[No Abstract] [Full Text] [Related]
14. Human herpes virus 8 (HHV-8) in Kaposi's sarcoma: lack of association with Bcl-2 and p53 protein expression.
Kennedy MM; O'Leary JJ; Oates JL; Lucas SB; Howells DD; Picton S; McGee JO
Mol Pathol; 1998 Jun; 51(3):155-9. PubMed ID: 9850339
[TBL] [Abstract][Full Text] [Related]
15. Early- and late-stage Kaposi's sarcoma lesions exhibit similar proliferation fraction.
De Thier F; Simonart T; Hermans P; André J; Van Vooren JP; Noel JC
Am J Dermatopathol; 1999 Feb; 21(1):25-7. PubMed ID: 10027521
[TBL] [Abstract][Full Text] [Related]
16. LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.
Long E; Ilie M; Hofman V; Havet K; Selva E; Butori C; Lacour JP; Nelson AM; Cathomas G; Hofman P
Virchows Arch; 2009 Aug; 455(2):159-70. PubMed ID: 19484260
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of c-Met in Kaposi's sarcoma according to progression stage and HIV infection status.
Puig L; Fernández-Figueras MT; Penín RM; Esquius M; Alomar A; Ariza A
J Cutan Pathol; 1999 May; 26(5):227-31. PubMed ID: 10408347
[TBL] [Abstract][Full Text] [Related]
19. p53 protein overexpression is a common but late event in the pathogenesis of iatrogenic and AIDS-related Kaposi's sarcoma.
Noel JC; De Thier F; Simonart T; Andre J; Hermans P; Van Vooren JP; Heenen M
Arch Dermatol Res; 1997 Oct; 289(11):660-1. PubMed ID: 9444391
[No Abstract] [Full Text] [Related]
20. [The clinical picture and treatment of HIV-associated Kaposi's sarcoma].
Plettenberg A; Dettke T; Meigel W
Dtsch Med Wochenschr; 1990 Jan; 115(3):106-13. PubMed ID: 2404729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
